ASPIC

A descoberta de alterações na família de receptores tirosina quinase (RTK- receptor tyrosine quinases) e nas suas vias de sinalização intracelular têm possibilitado o desenvolvimento de fármacos específicos para estas moléculas, que conduziram a tratamentos oncológicos inovadores, personalizados e mais eficazes. No entanto, a resistência a estas terapias surge com o tempo, levando à recidiva e evolução tumoral. Esta abordagem de medicina personalizada tem sido aplicada no tratamento de glioblastoma, o mais frequente e maligno tumor cerebral.

TRANSCAN-2 is launching its first Joint Transnational Call for research proposals (JTC 2014) to which the European Commission (EC) will contribute. TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research.

The topic of the call will be «Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy» and projects must cover at least one of the areas specified below, which are equal in relevance for this call:

TRANSCAN-2 is launching its first Joint Transnational Call for research proposals (JTC 2014) to which the European Commission (EC) will contribute. TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research.

The topic of the call will be «Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy» and projects must cover at least one of the areas specified below, which are equal in relevance for this call:

Paris Marriott Rive Gauche Hotel & Conference Center, Paris, France

4 – 6 September, 2015

See more informations here: http://www.ilca2015.org/sitecore/content/be-bruga/ilca2015/index.aspx

Paris Marriott Rive Gauche Hotel & Conference Center, Paris, France

4 – 6 September, 2015

See more informations here: http://www.ilca2015.org/sitecore/content/be-bruga/ilca2015/index.aspx

Anargyrios and Korgialenios School, Spetses, Greece

16 - 24 August,  2015

See more informations here: http://mcr.umcutrecht.nl/upcoming-events/spetses-2015/

Anargyrios and Korgialenios School, Spetses, Greece

16 - 24 August,  2015

See more informations here: http://mcr.umcutrecht.nl/upcoming-events/spetses-2015/

The Bute Hall, Glasgow University, Glasgow, Scotland

5 - 8 July, 2015

See more informations here: http://www.beatson.gla.ac.uk/beatson-conference/beatson-international-cancer-conference.html

The Bute Hall, Glasgow University, Glasgow, Scotland

5 - 8 July, 2015

See more informations here: http://www.beatson.gla.ac.uk/beatson-conference/beatson-international-cancer-conference.html

O investigador João T. Barata, do Instituto de Medicina Molecular (IMM), da Faculdade de Medicina da Universidade de Lisboa,  foi premiado com uma bolsa «Consolidator Grant» do European Research Council, ERC, pelo seu trabalho na área do cancro, mais especificamente na área das células IL-7.